277 related articles for article (PubMed ID: 26328927)
1. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours.
Park HS; Kim SY; Hong SM; Park SH; Lee SS; Byun JH; Kim JH; Kim HJ; Lee MG
Eur Radiol; 2016 May; 26(5):1348-58. PubMed ID: 26328927
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT.
Jang KM; Kim SH; Song KD; Kim YK; Lee SJ; Choi D
Clin Radiol; 2015 Feb; 70(2):153-60. PubMed ID: 25465293
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
[TBL] [Abstract][Full Text] [Related]
4. Solid pancreatic tumors with unilocular cyst-like appearance on CT: differentiation from unilocular cystic tumors using CT.
Lee JH; Byun JH; Kim JH; Lee SS; Kim HJ; Lee MG
Korean J Radiol; 2014; 15(6):704-11. PubMed ID: 25469081
[TBL] [Abstract][Full Text] [Related]
5. CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification.
Sun HY; Kim SH; Kim MA; Lee JY; Han JK; Choi BI
Eur J Radiol; 2010 Aug; 75(2):e45-55. PubMed ID: 20056368
[TBL] [Abstract][Full Text] [Related]
6. Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour.
Manfredi R; Bonatti M; Mantovani W; Graziani R; Segala D; Capelli P; Butturini G; Mucelli RP
Eur Radiol; 2013 Nov; 23(11):3029-39. PubMed ID: 23793519
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic serous cystic neoplasms accompanying other pancreatic tumors.
Kim SW; Song IH; An S; Kim SY; Kim HJ; Song KB; Hwang DW; Lee SS; Byun JH; Seo DW; Kim SC; Yu E; Hong SM
Hum Pathol; 2017 Feb; 60():104-113. PubMed ID: 27816717
[TBL] [Abstract][Full Text] [Related]
8. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
10. The "extracapsular cystic" sign in pancreatic serous cystic neoplasms: A clinicopathologic study of 177 patients with cystic pancreatic lesions.
Chen HY; Zhao J; Lu YF; Lv SY; Chen JY; Pan Y; Shi D; Xu XF; Yu RS
Eur J Radiol; 2018 Sep; 106():167-172. PubMed ID: 30150040
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas.
Kang BK; Kim JH; Byun JH; Lee SS; Kim HJ; Kim SY; Lee MG
Acta Radiol; 2014 Dec; 55(10):1157-65. PubMed ID: 24259300
[TBL] [Abstract][Full Text] [Related]
13. Serous pancreatic neoplasia, data and review.
Dietrich CF; Dong Y; Jenssen C; Ciaravino V; Hocke M; Wang WP; Burmester E; Moeller K; Atkinson NS; Capelli P; D'Onofrio M
World J Gastroenterol; 2017 Aug; 23(30):5567-5578. PubMed ID: 28852316
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.
Kawamoto S; Johnson PT; Shi C; Singhi AD; Hruban RH; Wolfgang CL; Edil BH; Fishman EK
AJR Am J Roentgenol; 2013 Mar; 200(3):W283-90. PubMed ID: 23436873
[TBL] [Abstract][Full Text] [Related]
15. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
17. CT classification model of pancreatic serous cystic neoplasms and mucinous cystic neoplasms based on a deep neural network.
Yang R; Chen Y; Sa G; Li K; Hu H; Zhou J; Guan Q; Chen F
Abdom Radiol (NY); 2022 Jan; 47(1):232-241. PubMed ID: 34636931
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
[TBL] [Abstract][Full Text] [Related]
19. Serous Cystic Neoplasms of the Pancreas: Endoscopic Ultrasonographic Versus Computed Tomography and Magnetic Resonance Imaging Features of Surgically Removed Masses.
Hwang H; Yu JS; Cho ES; Kim JH; Chung JJ
Ultrasound Q; 2018 Sep; 34(3):122-127. PubMed ID: 29509575
[TBL] [Abstract][Full Text] [Related]
20. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
Kim HS; Kim SH; Kang TW; Song KD; Choi D; Park CK
Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
